Legal Framework for the Use of Psychedelics in Switzerland
Cannabis Law Report
JULY 24, 2022
The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years [1]. Psilocybin was first extracted and identified in 1958. percent annually to $9.8 billion by 2029. [1]
Let's personalize your content